Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015

Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2669CTIDB
  • |
  • Pages: 62
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015" provides data on the Shigella Infections (Shigellosis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Shigella Infections (Shigellosis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Shigella Infections (Shigellosis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Shigella Infections (Shigellosis) 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Top Countries Contributing to Clinical Trials in Middle East and Africa 12

Clinical Trials by G7 Countries: Proportion of Shigella Infections (Shigellosis) to Infectious Disease Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by Phase 16

Clinical Trials by Trial Status 17

Clinical Trials by End Point Status 18

Unaccomplished Trials of Shigella Infections (Shigellosis) 19

Subjects Recruited Over a Period of Time 21

Clinical Trials by Sponsor Type 22

Prominent Sponsors 23

Top Companies Participating in Shigella Infections (Shigellosis) Therapeutics Clinical Trials 24

Prominent Drugs 25

Clinical Trial Profiles 26

Clinical Trial Overview of Top Companies 26

GlaxoSmithKline plc 26

Clinical Trial Overview of GlaxoSmithKline plc 26

Novartis AG 27

Clinical Trial Overview of Novartis AG 27

Icddr,b 28

Clinical Trial Overview of Icddr,b 28

Clinical Trial Overview of Top Institutes / Government 29

Eunice Kennedy Shriver National Institute of Child Health and Human Development 29

Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 29

University of Maryland 30

Clinical Trial Overview of University of Maryland 30

Institut Pasteur 31

Clinical Trial Overview of Institut Pasteur 31

PATH 32

Clinical Trial Overview of PATH 32

U.S. Army Medical Research and Materiel Command 33

Clinical Trial Overview of U.S. Army Medical Research and Materiel Command 33

U.S. Department of Defense 34

Clinical Trial Overview of U.S. Department of Defense 34

University of Maryland, Baltimore 35

Clinical Trial Overview of University of Maryland, Baltimore 35

University of Oxford 36

Clinical Trial Overview of University of Oxford 36

Five Key Clinical Profiles 37

Appendix 60

Abbreviations 60

Definitions 60

Research Methodology 61

Secondary Research 61

About GlobalData 62

Contact Us 62

Disclaimer 62

Source 62

List of Figures

Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 10

Proportion of Shigella Infections (Shigellosis) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 13

Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16

Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Shigella Infections (Shigellosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

GlobalData Methodology 61

List of Tables

Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Region, 2015* 6

Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Europe, Top Countries, 2015* 10

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, North America, Top Countries, 2015* 11

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12

Proportion of Shigella Infections (Shigellosis) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 13

Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Phase, 2015* 16

Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18

Shigella Infections (Shigellosis) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 19

Shigella Infections (Shigellosis) Therapeutics, Global, Terminated Clinical Trials, 2015* 20

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Shigella Infections (Shigellosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 26

Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 27

Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Icddr,b, 2015* 28

Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 29

Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland, 2015* 30

Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Pasteur, 2015* 31

Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by PATH, 2015* 32

Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical Research and Materiel Command, 2015* 33

Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Defense, 2015* 34

Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland, Baltimore, 2015* 35

Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2015* 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

GlaxoSmithKline plc

Novartis AG

Icddr,b

Shigella Infections (Shigellosis) Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Shigella Infections (Shigellosis), Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 160650
Site License
USD 5000 INR 321300
Corporate User License
USD 7500 INR 481950

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com